Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Supplement—May 2025

SUPPLEMENT ISSUE
Supplement

Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States

Kien Pham1, Chrispin Chaguza, Rafael Lopes, Ted Cohen, Emma Taylor-Salmon, Melanie Wilkinson, Volha Katebi, Nathan D. Grubaugh, and Verity HillComments to Author 
Author affiliation: Yale School of Public Health, New Haven, Connecticut, USA (K. Pham, C. Chaguza, R. Lopes, T. Cohen, E. Taylor-Salmon, N.D. Grubaugh, V. Hill); Yale School of Medicine, New Haven (E. Taylor-Salmon); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Wilkinson, V. Katebi); Yale University, New Haven (N.D. Grubaugh)

Main Article

Figure 3

Ten regions of the United States evaluated in large-scale genomic analysis of SARS-CoV-2 Omicron BA.5 emergence. Regions have been designated by the US Department of Health and Human Services (https://www.hhs.gov/about/agencies/regional-offices/index.html).

Figure 3. Ten regions of the United States evaluated in large-scale genomic analysis of SARS-CoV-2 Omicron BA.5 emergence. Regions have been designated by the US Department of Health and Human Services (https://www.hhs.gov/about/agencies/regional-offices/index.html).

Main Article

1Current affiliation: Program for Appropriate Technology in Health (PATH) Southeast Asia, and Hanoi Medical University, Hanoi, Vietnam.

Page created: March 24, 2025
Page updated: May 12, 2025
Page reviewed: May 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external